Compare Avalon Labs (AVL) vs Mitosis (MITO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avalon Labs vs Mitosis — how do they compare? Avalon Labs trades at Rp398.63 (market cap Rp66,23M, Rp100,12M 24h volume), while Mitosis trades at Rp380.81 (market cap Rp69,46M, Rp106,21M 24h volume). The key difference: Avalon Labs and Mitosis are close in size by market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 8 Days and Mitosis for 19 Days on average.
| AVL | MITO | |
|---|---|---|
Market Cap | Rp66,23M | Rp69,46M |
Volume (24h) | Rp100,12M | Rp106,21M |
Circulating Supply | 161,7M / 1B AVL (17%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 8 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL trades at Rp392.75 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token hovers near support at Rp393, with resistance at Rp409. Market cap is Rp66.43M with 17% of max supply circulating. Recent news lacks crypto-specific updates, focusing incorrectly on corporate activities.
Outlook remains cautious due to weak technicals and low liquidity. Key risks include high volatility and limited adoption. Opportunities exist if the project gains ecosystem traction, but current fundamentals show no significant developments for token holders.
Mitosis (MITO) is trading at Rp393.33 with a market cap of Rp71.86 million, showing a bearish technical outlook as moving averages signal strong selling pressure while oscillators remain neutral. The token's low circulating supply of 181,300 out of 1 million tokens and short average hold time of 19 days suggest high volatility. Recent news highlights a strategic acquisition involving MITO Material Solutions, though this pertains to a corporate entity and not the cryptocurrency's ecosystem.
Overall outlook is cautious due to bearish technical signals and limited liquidity. Key opportunities include potential price rebounds from oversold RSI levels, but major risks involve low market cap volatility, minimal exchange presence, and lack of clear token utility updates. Investors should monitor for genuine protocol developments rather than unrelated corporate news.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
